Product Reports Resources Pricing Login Book a demo

Avidity Biosciences

Biotech & Life Sciences · San Diego, United States · Founded 2013 · IPO 2020

Research, development, and manufacturing of drug candidates which include antibody-sirna complexes

Valuation $12B
Revenue $8.0M

Talent graph

Avidity Biosciences's talent

Book a demo to see the people
Founders Hidden — book a demo/100 quality score
Key operators 7 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia 4 alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Investors

18 investors on Avidity Biosciences's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 18 investors entered at this stage
Takeda
Cormorant Asset Management
F-Prime
Brace Pharma
Janus Henderson Investors
Alethea Capital Management
Adage Capital
Farallon Capital Management
Eli Lilly
Perceptive Advisors
EcoR1 Capital
Wellington Management
Boxer Capital
Casdin Capital
Logos Capital
Moore Venture Partners
RA Capital Management
RTW Investments

Global footprint

Where Avidity Biosciences has talent and traffic

Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown
Web traffic by country
16K monthly visits
across markets
🇺🇸 United States69.4%
🇬🇧 United Kingdom11.3%
🇮🇳 India8.8%
🇯🇵 Japan5%
🇫🇷 France3.1%
Top 5 markets shown

Patent intelligence

$56M patent portfolio · 39 active families

Estimated portfolio value
$56M
0.47% of market cap · 14× smaller than top peer BioNTech ($788M)
39 active patent families
Where Avidity Biosciences innovates Antiendomysial antibodiesBiochemistryDiseaseMoietyMolecular biology

Where Avidity Biosciences concentrates vs peers

Each axis is a top-10 topic across Avidity Biosciences and its closest peers. #1 = 100, #10 = 10, absent = 0.

Compare against

Source: Dealroom Patent Intelligence · Patsnap. Request a demo for the full per-sub-category breakdown, individual records, and quality-score history.

Market sentiment

What the market is saying about Avidity Biosciences

An AI-synthesized read of the highest-engagement posts about Avidity Biosciences on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Avidity Biosciences on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.